Abstract The extraneuronal monoamine transporter EMT (HGNC Nomenclature SLC22A3) is the molecular correlate of the classical uptake 2 system responsible for the non-neuronal inactivation of circulating and centrally released catecholamines. Because of its functional profile and expression pattern, EMT is regarded as a candidate gene for diseases related to the sympathetic nervous system and neuropsychiatric disorders. We describe the first investigation of the genetic variability of the EMT gene in human. Six single-nucleotide substitutions and one deletion were detected within the assumed core promoter, the exonic and flanking intronic sequences and the 3'-untranslated region in 100 Caucasian individuals. No amino acid changes were found and Tajima's D was positive (D=2.91; P<0.01). However, the synonymous nucleotide substitution 1233G fi A might serve as a cryptic splice acceptor site. Analysis of linkage disequilibrium between polymorphisms yielded 12 possible haplotypes accounting for more than 90% of all haplotypes. Knowledge of the sequence variation and frequency of the underlying polymorphisms in this member of the amphiphilic solute facilitator family of transporters provides the basis for subsequent association studies and candidate gene approaches.
Introduction
Catecholamine signal transduction regulates various physiological functions, such as blood pressure, lipid metabolism, pituitary-adrenocortical axis, immune system and behaviour (Mark 1996; Arner 2001; Bugajski et al. 1998; Sanders and Straub 2002; Brunner et al 1993) . Disorders in catecholaminergic signalling are related to common diseases, such as hypertension, congestive heart failure, Parkinson's disease and addiction (Rumantir et al. 2000; Packer et al. 1996; Wooten and Trugman 1989; Mash et al 2002) . The effect of released catecholamines is terminated by reuptake mechanisms via two distinct transport systems. In addition to high-affinity low-capacity transport into releasing neurons (Pacholczyk et al. 1991) , the inactivation of catecholamines is mediated by a lowaffinity high-capacity non-neuronal system, originally named uptake 2 (Iversen 1965) .
The extraneuronal monoamine transporter EMT has been identified as the molecular correlate that participates in the inactivation of circulating and centrally released catecholamines (Graefe et al. 1998; Russ et al. 1996; Scho¨mig et al. 1998) . Furthermore, as a member of the amphiphilic solute facilitator (ASF) family EMT is thought to play a pivotal role in the elimination of cationic xenobiotics (Chen et al. 1999) .
Because of its functional profile and expression in sympathetically innervated tissues, EMT is a candidate gene for common disorders such as hypertension, obesity or neuropsychiatric diseases Eisenhofer 2001) . The pathogenetic significance of polymorphisms has been reported for neuronal catecholamine transporters (Shannon et al. 2000; Lesch et al. 1996) .
The path for studying EMT has recently been paved by revealing its genetic structure (Gru¨ndemann and Scho¨mig 2000) . We report the first investigation of the genetic variability of EMT in 100 unrelated individuals of Caucasian origin.
Materials and methods

Subjects
Genomic DNA from 100 unrelated healthy Caucasian individuals was used to sequence directly the assumed core promoter region 500 bp upstream of the transcription starting point and all 11 exons including exon-intron boundaries and part of the 3'-untranslated region (3'-UTR). The sample size permitted the detection of alleles at a frequency of 0.05 with a power of more than 99.9% and the detection of alleles at a frequency of 0.01 with a power of more than 86%. Genomic DNA was extracted by the Blood and Cell Midi Kit (QIAgen).
Informed consent
All persons gave their written informed consent prior to inclusion in the study. The study design was approved by the appropriate ethics committee.
Basic molecular biology
Polymerase chain reaction (PCR) was performed for promoter and exon 1 (5 min at 94°C as the denaturation step, 40 cycles of 1 min at 94°C and 2 min at 68°C, and 10 min at 72°C as the final elongation) in 50-ll reaction mixtures containing 100 ng genomic DNA, 1· Pfx amplification buffer, 1 mM MgSO 4 , 0.5 lM each primer, 0.3 mM each dNTP, 1 M formamide, 5% dimethylsulphoxide and 1.25 U Platinum Pfx DNA Polymerase (Life Technologies). PCR for exons 2-11 (34 cycles of 30 s at 94°C, 1 min at 60°C, and 1 min at 72°C, and 10 min at 72°C as the final elongation) was carried out in 50-ll reaction mixtures containing 100 ng genomic DNA, 10 mM TRIS-HCl (pH 9.0), 50 mM KCl, 2.3 mM MgCl 2 , 0.5 lM each primer, 0.2 mM each dNTP and 1.5 U Taq DNA polymerase (Promega, Storage Buffer A). Before being used in PCR, genomic DNA was restricted by EcoRV. PCR products were separated on UV-protected 1.6% agarose gels (Gru¨ndemann and Scho¨mig 1996) , visualized with ethidium bromide under UV-light and purified by employing the QiaQuick Gel Extraction kit (QIAgen). Oligonucleotides used for amplification are shown in Table 1 .
Direct sequencing was carried out with the ABI Prism BigDye Terminator Cycle Sequencing Ready Reaction v2.0 (Applied Biosystems) under the following conditions. Promoter and exon 1 (5 min at 98°C for preincubation without Reaction Mix, short incubation on ice, addition of Reaction Mix, 5 min at 94°C as an initial denaturation step, 25 cycles of 1 min at 94°C and 4 min at 68°C with a ramping speed of 1°C/s, and 10 min at 68°C as the final elongation) were sequenced in 20-ll reaction mixtures containing 50 ng PCR product as template, 4 ll Terminator Ready Reaction Mix, 0.3 lM sequencing primer and 5% DMSO. Exons 2-11 (25 cycles of 10 s at 96°C, 30 s at 55°C and 4 min at 60°C with a ramping speed of 1°C/s) were sequenced in 10-ll reaction mixtures containing 50 ng PCR product as template, 2 ll Terminator Ready Reaction Mix and 0.3 lM sequencing primer. The sequencing products were purified by employing Sephadex G50 superfine (Sigma-Aldrich) and MAHVN030 96-well plates (Millipore). Sequencing analysis was performed on an Applied Biosystems Genetic Analyzer 3100 capillary sequencer. Pairwise sequence alignments were performed with the MT Navigator PPC and Edit View 1.0.1 programs (ABI).
For direct sequencing the following oligonucleotides were used (5'-end first): CTC GTC GAA GGA GGG CAT GGT, ACG CGC AAG GGC, CGG GCG GTG CGG CCT GAC TAC G (promoter), CCG CCG GCT GGG TCC GCG, CCT CCC CTG GCG GCC (exon 1), CCT CCC CTG GCG GCC AGC GTC TCA CA (exon 2), GAG GAA GGT TGA TTA ACT AGC ATT T (exon 3), GTA ACA GGT GTA ACA TCT CTG TAT T (exon 4), GCA ACA TTA AGT ACA CAA GAA GCA ACA AAA (exon 5), TAG GTG TTT TCA AGT CCT TT (exons 6/7), CTG AGC TAA GGA AAC GAC TTC ATA GTT TT (exon 8), CAA AGT ATC TTC ACA CTT CCT TTG GTT TT (exon 9), GTC ATT CTT TCC CCC GTG GTT TT (exon 10), CCT TAG AGT TGG GTT TTC ATG AAT GT (exon 11).
Genbank accession numbers
Reference sequences NT_029991 and XM_011436 are available from the GenBank database.
Statistical analysis
Haplotype frequency was estimated by using the EH plus program (Xie and Ott 1993; Terwilliger and Ott 1994) . For the calculation of the population mutation parameter h, based on the number of segregating sites, nucleotide diversity p, Tajima's D, Lewontin's coefficient D' (Lewontin 1984) and standardized linkage disequilibrium coefficient r (Hill and Robertson 1968) , DnaSP version 3.53 software was employed (Rozas and Rozas 1999 (Lewontin 1984) . The standardized linkage disequilibrium coefficient, r, is given by D/(p 1 p 2 q 1 q 2 ) 1/2 , where q 1 and q 2 are the frequencies of the other alleles at loci A and B, respectively (Hill and Robertson 1968) .
Results
Genetic variation of the EMT gene
Six single-nucleotide substitutions and one deletion were identified within the putative core promoter, all 11 exons, exon-intron boundaries and part of the 3'-UTR in 100 healthy unrelated individuals of Caucasian descent. Interestingly, no non-synonymous nucleotide substitutions and solely transitions were found. Polymorphisms 603T fi C and IVS9 )60delC were novel and had not previously been published by the National Center for Biotechnology Information. The deletion is situated within a short 8-bp palindromic sequence that might serve as a hot spot to promote mutations ( Table 2 ). The nucleotide diversity p was calculated (6.7± 4.0)*10 -4 for 3686 bp genomic sequence and (7.1± 4.1)*10 -4 for 1926 bp exonic sequence, i.e. there was one single-nucleotide polymorphism (SNP) every 1550 bp on average. The mutation parameter h was estimated as (2.8±1.3)*10 -4 for the whole sequence and (3.5±1.9)*10 -4
for the exonic region. At synonymous sites, p and h were computed as (23.3±13.4)*10 -4 and (11.9±4.8)*10 -4 , respectively, whereas at non-synonymous sites p and h valued 0, since there were no amino acid changes.
Remarkably, Tajima's D for the genomic sequence investigated was 2.91, formally discarding the null hypothesis of selective neutrality at P<0.01 (Tajima 1989) .
No evidence for the functional importance of any of the polymorphisms detected could be found since there was only inheritance in Mendelian ratios. On the other hand, the G fi A substitution at position 1233 in exon 7 changes the two codons for alanine GCGGCA to the sequence GCAGCA and opens the theoretical option for a cryptic splice acceptor site with the consequence of a loss of coding sequence and a frameshift further downstream (Fig. 1) . The variant sequence CAG/CA matches the C 65 A 100 G 100 /N rule for splice acceptor sites and is directly preceeded by 10 pyrimidine bases. Additionally, further upstream there is a possible branch site (Strachan and Read 1999) .
Haplotype analysis
Haplotypes may provide an even more powerful tool for detecting disease association (Stephens et al. 2001) .
Consequently, haplotype analysis utilizing an iterative procedure was performed yielding the occurrence of 20 possible haplotypes. Twelve of them (representing over 90% of calculated haplotypes) are displayed in Table 3 .
Strong, but incomplete, linkage disequilibrium was detected among some of the six prevalent polymorphisms (Table 4) . Recombination events, e.g. by cross-over or gene conversions, occurred in between segregating sites )29A fi G/360T fi C, 360T fi C/ 1233G fi A, 1233G fi A/IVS9 )60delC, IVS9 )60delC/IVS9 )50G fi A and IVS9 )50G fi A/ 1734C fi T.
Discussion
Catecholamine signalling pathways control elementary physiological functions, such as blood pressure homeostasis, affection and cognition. Catecholaminergic actions are cancelled by inactivation through neuronal and non-neuronal transport systems. The extraneuronal monoamine transporter EMT (the correlate of the classical uptake 2 system) has been hypothesized to contribute to the pathogenesis of common autonomic and psychiatric disorders.
We have carried out the first analysis of the genetic variation of EMT and detected six SNPs and one deletion within the presumed core promoter and coding and adjacent non-coding sequence in 100 Caucasians. The Fig. 1 The 1233G fi A polymorphism within exon 7 fulfils criteria of a cryptic 3'-splice acceptor site 1233G fi A polymorphism might serve as a cryptic splice acceptor site within certain tissues; this requires further investigation. Nonetheless, as a striking result, there were no amino acid changes and Tajima's D was significantly positive. Interestingly, a recent analysis of the genetic variation of the nearby transporter genes OCT1 and OCT2 has revealed the occurrence of amino acid substitutions (Saito et al. 2002; Leabman et al. 2002) . The absence of non-synonymous mutations in the EMT gene and the positive value of Tajima's D might result from selective mechanisms that operated during evolution of the human species against amino acid changes (Tajima 1989) but could also be caused by demographic factors such as population subdivision (Simonsen et al. 1995) . The investigation of different ethnic groups might detect population-specific non-synonymous polymorphisms within the EMT gene that are not prevalent in Caucasians. Furthermore, Tajima's test makes various assumptions, e.g. no recombination or random mating, both of which are violated within human populations. The nucleotide diversity p and mean SNP density were only slightly lower than that reported for chromosome 6 (7.44*10 -4 ) and whole-genome mean SNP spacing (1209 bases per SNP; International SNP Map Working Group 2001; http://www.ncbi.nlm.nih.gov/SNP/snp_summa-ry.cgi). On the other hand, the mean value of the mutation parameter h was well below the estimates for h (9.6*10 -4 and 8.3*10 -4 ) given by others (Stephens et al. 2001; Halushka et al. 1999) . This difference can in part be explained by the investigation of a large number of genes and ethnically diverse samples in these studies.
Lack of protein sequence variation may reflect the crucial role of EMT within the human organism. The investigation of patients with candidate disorders might reveal deleterious polymorphisms that occur at low prevalence and that were not found in our study of healthy individuals.
Nevertheless, the data of non-coding polymorphisms can successfully be utilized to perform linkage disequilibrium analysis and to extract information about disease association, as provided by the example of the calpain 10 gene and type 2 diabetes mellitus (Horikawa et al. 2000) . The data at hand further expand our knowledge about this member of the ASF family of transporters and provide the basis for subsequent association studies and candidate gene approaches. Haplotypes at an estimated frequency of greater than 2.5% representing over 90% of sequences are shown 
